Literature DB >> 12620941

Arrhythmogenic potential of antiemetics: perspectives on risk-benefits.

Donald R Miller.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12620941     DOI： 10.1007/BF03017787

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN： 0832-610X            Impact factor:   5.063


× No keyword cloud information.
  2 in total

1.  Effect of intravenous ondansetron on QT interval prolongation in patients with cardiovascular disease and additional risk factors for torsades: a prospective, observational study.

Authors:  Matthew J Hafermann; Rocsanna Namdar; Gretchen E Seibold; Robert Lee Page
Journal:  Drug Healthc Patient Saf       Date:  2011-10-03

2.  Reappraisal of the role of dolasetron in prevention and treatment of nausea and vomiting associated with surgery or chemotherapy.

Authors:  S Michael Roberts; Dmitri S Bezinover; Piotr K Janicki
Journal:  Cancer Manag Res       Date:  2012-02-24       Impact factor: 3.989
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.